DSW (DSW) (REGN) (RMTI) (RSTI) (DBLE) (DEI) Upgraded

DSW (NYSE: DSW), Regeneron Pharma (NASDAQ: REGN), Rockwell Medical (NASDAQ: RMTI), Rofin-Sinar Technologies (NASDAQ: RSTI), Double Eagle Petroleum (NASDAQ: DBLE) and Douglas Emmett (NYSE: DEI) were upgraded by analysts.

Regeneron Pharma (REGN) was upgraded by Robert W. Baird from a “Neutral” rating to an “Outperform” rating. They have a price target of $81.00 on the company, up from $56.00.

Rockwell Medical (RMTI) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

Rofin-Sinar Technologies (RSTI) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

Double Eagle Petroleum (DBLE) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

Douglas Emmett (DEI) was upgraded by Raymond James (NYSE:RJF) from a “Market Perform” rating to an “Outperform” rating.

DSW (DSW) was upgraded by Zacks Investment Research from a “Neutral” rating to an “Outperform” rating.